• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非系统性硬化症患者的间质性肺疾病。

Interstitial lung disease in South Africans with systemic sclerosis.

机构信息

Division of Rheumatology, Department of Medicine, Faculty of Health Sciences, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.

Division of Pulmonology, Department of Medicine, Faculty of Health Sciences, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

Rheumatol Int. 2018 Apr;38(4):657-662. doi: 10.1007/s00296-017-3893-0. Epub 2017 Nov 28.

DOI:10.1007/s00296-017-3893-0
PMID:29185086
Abstract

To investigate the frequency, severity and predictors of interstitial lung disease (ILD) in a cohort of South Africans with systemic sclerosis (SSc). Retrospective record review of SSc patients attending a tertiary Connective Tissue Diseases Clinic. Patients with ILD, defined by a combination of clinical findings, imaging, and lung function tests were compared to patients without ILD in terms of demographics, clinical features and autoantibodies. The majority (86.8%) of the 151 patients included were of Black ethnicity, 40% had ILD, of whom 39% had moderate-severe lung disease. Univariate predictors of ILD included: disease duration (OR 1.08, 95% CI 1.01-1.15); cough (OR 2.93, 95% CI 1.37-6.29); dyspnoea (OR 2.44, 95% CI 1.23-4.87); bibasal crackles (OR 7.58, 95% CI 3.31-17.37); diffuse cutaneous SSc (dcSSc) (OR 4.55, 95% CI 2.10-9.86) and a speckled anti-nuclear antibody (ANA) pattern (OR 2.47, 95% CI 1.25-4.90). Conversely, limited cutaneous disease (OR 0.22, 95% CI 0.09-0.50) and anti-centromere antibody (ACA) (OR 0.12, 95% CI 0.02-0.97) were protective. Independent predictors of ILD on multivariate analysis were bibasal crackles (OR 9.43, 95% CI 3.25-27.39), disease duration (OR 1.19, 95% CI 1.09-1.30) and speckled ANA (OR 2.95, 95% CI 1.22-7.15). Almost all (86.4%) patients received immunosuppressive treatment and the leading cause of death was related to ILD itself (44.4%). In this cohort of predominantly Black South Africans, SSc ILD was common and carried a poor prognosis. ILD occurred mainly, but not exclusively, in patients with dcSSc, especially those with a speckled ANA pattern. Conversely, the presence of ACA was protective against ILD.

摘要

调查南非系统性硬化症(SSc)患者中特发性肺纤维化(ILD)的频率、严重程度和预测因素。回顾性记录分析在三级结缔组织疾病诊所就诊的 SSc 患者。ILD 患者的定义为临床发现、影像学和肺功能检查相结合,与无 ILD 的患者相比,在人口统计学、临床特征和自身抗体方面进行比较。在纳入的 151 名患者中,大多数(86.8%)为黑人,40%有 ILD,其中 39%有中重度肺病。ILD 的单变量预测因素包括:疾病持续时间(OR 1.08,95%CI 1.01-1.15);咳嗽(OR 2.93,95%CI 1.37-6.29);呼吸困难(OR 2.44,95%CI 1.23-4.87);双基底爆裂声(OR 7.58,95%CI 3.31-17.37);弥漫性皮肤 SSc(dcSSc)(OR 4.55,95%CI 2.10-9.86)和斑点状抗核抗体(ANA)模式(OR 2.47,95%CI 1.25-4.90)。相反,局限性皮肤疾病(OR 0.22,95%CI 0.09-0.50)和抗着丝点抗体(ACA)(OR 0.12,95%CI 0.02-0.97)具有保护作用。多变量分析中 ILD 的独立预测因素为双基底爆裂声(OR 9.43,95%CI 3.25-27.39)、疾病持续时间(OR 1.19,95%CI 1.09-1.30)和斑点状 ANA(OR 2.95,95%CI 1.22-7.15)。几乎所有(86.4%)患者都接受了免疫抑制治疗,主要死亡原因与 ILD 本身有关(44.4%)。在这组主要为黑人的南非患者中,SSc ILD 很常见,预后不良。ILD 主要发生在,但不仅限于,dcSSc 患者中,尤其是具有斑点状 ANA 模式的患者。相反,ACA 的存在可预防 ILD。

相似文献

1
Interstitial lung disease in South Africans with systemic sclerosis.南非系统性硬化症患者的间质性肺疾病。
Rheumatol Int. 2018 Apr;38(4):657-662. doi: 10.1007/s00296-017-3893-0. Epub 2017 Nov 28.
2
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.免疫抑制治疗与系统性硬化症中轻度间质性肺疾病病程的关联
Rheumatology (Oxford). 2020 May 1;59(5):1108-1117. doi: 10.1093/rheumatology/kez407.
3
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.系统性硬化症的间质性肺疾病:来自西班牙硬皮病研究组的数据。
Rheumatol Int. 2018 Mar;38(3):363-374. doi: 10.1007/s00296-017-3916-x. Epub 2018 Jan 10.
4
Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study.泰国早期系统性硬化症患者间质性肺疾病(ILD)的发病率及预测因素:队列起始研究
Mod Rheumatol. 2016 Jul;26(4):588-93. doi: 10.3109/14397595.2015.1115455. Epub 2015 Dec 23.
5
Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study.系统性硬化症和系统性硬化症相关间质性肺病的疾病频率、患者特征、合并症结局和免疫抑制治疗:一项美国队列研究。
Rheumatology (Oxford). 2021 Apr 6;60(4):1915-1925. doi: 10.1093/rheumatology/keaa547.
6
Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.系统性硬化症相关间质性肺疾病的诊断和预后临床算法。
Semin Arthritis Rheum. 2017 Oct;47(2):228-234. doi: 10.1016/j.semarthrit.2017.03.019. Epub 2017 Apr 1.
7
Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.血清 Krebs von den Lungen-6 水平升高与系统性硬化症:肺纤维化和疾病严重程度的标志物。
Rheumatol Int. 2018 May;38(5):813-819. doi: 10.1007/s00296-018-3987-3. Epub 2018 Feb 17.
8
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis.系统性硬皮病相关间质性肺疾病患者的性别影响:EUSTAR 数据库分析。
Rheumatology (Oxford). 2023 Jul 5;62(7):2483-2491. doi: 10.1093/rheumatology/keac660.
9
Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: A systematic review and meta-analysis.东亚系统性硬化症相关间质性肺病的患病率及相关危险因素:系统评价和荟萃分析。
Int J Rheum Dis. 2021 Dec;24(12):1449-1459. doi: 10.1111/1756-185X.14206. Epub 2021 Aug 21.
10
[Characteristics of patients with systemic sclerosis who develop interstitial lung disease].[发生间质性肺疾病的系统性硬化症患者的特征]
Rev Med Inst Mex Seguro Soc. 2023 Oct 2;61(Suppl 3):S363-S371. doi: 10.5281/zenodo.8383951.

引用本文的文献

1
A Practical Multidisciplinary Approach to Identifying Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases: A Clinician's Narrative Review.一种识别系统性自身免疫性风湿性疾病中间质性肺疾病的实用多学科方法:临床医生的叙述性综述
Diagnostics (Basel). 2024 Nov 27;14(23):2674. doi: 10.3390/diagnostics14232674.
2
Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention.针对肺纤维化进展:潜在机制、分子生物标志物及治疗干预概述
Life (Basel). 2024 Feb 6;14(2):229. doi: 10.3390/life14020229.
3
[Characteristics of patients with systemic sclerosis who develop interstitial lung disease].

本文引用的文献

1
Scleroderma lung disease.硬皮病肺病
Eur Respir Rev. 2013 Mar 1;22(127):6-19. doi: 10.1183/09059180.00005512.
2
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.EUSTAR 队列概况更新:对 EULAR 硬皮病试验和研究组数据库的分析。
Ann Rheum Dis. 2012 Aug;71(8):1355-60. doi: 10.1136/annrheumdis-2011-200742. Epub 2012 May 21.
3
A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.非裔美国人和白人系统性硬化症患者的临床及血清学比较
[发生间质性肺疾病的系统性硬化症患者的特征]
Rev Med Inst Mex Seguro Soc. 2023 Oct 2;61(Suppl 3):S363-S371. doi: 10.5281/zenodo.8383951.
4
Epidemiology and Treatment of Systemic Sclerosis in Korea.韩国系统性硬化症的流行病学与治疗
J Rheum Dis. 2022 Oct 1;29(4):200-214. doi: 10.4078/jrd.22.0029.
5
Interstitial lung disease in patients with connective tissue disease: Subtypes, clinical features and comorbidities in the Western Cape, South Africa.结缔组织病患者的间质性肺疾病:南非西开普省的亚型、临床特征及合并症
Afr J Thorac Crit Care Med. 2022 Jul 18;28(2). doi: 10.7196/AJTCCM.2022.v28i2.213. eCollection 2022.
6
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice.自身免疫性风湿性疾病相关间质性肺疾病:临床实践清单
Front Med (Lausanne). 2021 Oct 15;8:732761. doi: 10.3389/fmed.2021.732761. eCollection 2021.
7
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review.系统性硬化症相关间质性肺疾病患者管理的近期证据评估:一项系统综述
ERJ Open Res. 2021 Feb 22;7(1). doi: 10.1183/23120541.00235-2020. eCollection 2021 Jan.
8
Systemic sclerosis in sub-Saharan Africa: a systematic review.撒哈拉以南非洲的系统性硬化症:系统评价。
Pan Afr Med J. 2020 Oct 22;37:176. doi: 10.11604/pamj.2020.37.176.22557. eCollection 2020.
9
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies.自身抗体作为特发性炎症性肌病和系统性硬化症中间质性肺病的生物标志物:以抗真核生物翻译起始因子2B(eIF2B)抗体为例
J Transl Autoimmun. 2020 Mar 31;3:100049. doi: 10.1016/j.jtauto.2020.100049. eCollection 2020.
10
Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma.线粒体、衰老和细胞衰老:对硬皮病的影响。
Curr Rheumatol Rep. 2020 Jun 19;22(8):37. doi: 10.1007/s11926-020-00920-9.
Arthritis Rheum. 2012 Sep;64(9):2986-94. doi: 10.1002/art.34482.
4
Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.C 反应蛋白与系统性硬化症高疾病活动度的相关性:来自加拿大硬皮病研究组的研究结果。
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716.
5
Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.系统性硬化症的流行病学:发病率、患病率、生存率、危险因素、恶性肿瘤和环境触发因素。
Curr Opin Rheumatol. 2012 Mar;24(2):165-70. doi: 10.1097/BOR.0b013e32834ff2e8.
6
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis.用于预测系统性硬化症中存在间质性肺病的临床决策规则。
Arthritis Care Res (Hoboken). 2012 Apr;64(4):519-24. doi: 10.1002/acr.21583.
7
Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study.硬皮病相关性间质性肺病咳嗽与疾病活动度及环磷酰胺治疗的相关性:硬皮病肺研究的结果。
Chest. 2012 Sep;142(3):614-621. doi: 10.1378/chest.11-0801.
8
Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease.预测硬皮病相关间质性肺疾病的治疗结果和反应亚组。
Arthritis Rheum. 2011 Sep;63(9):2797-808. doi: 10.1002/art.30438.
9
Interstitial lung disease in systemic sclerosis.系统性硬皮病中的间质性肺疾病。
Autoimmun Rev. 2011 Mar;10(5):248-55. doi: 10.1016/j.autrev.2010.09.012. Epub 2010 Sep 21.
10
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.早期系统性硬化症中肺间质疾病的预测因素:GENISOS 队列的前瞻性纵向研究。
Arthritis Res Ther. 2010;12(5):R166. doi: 10.1186/ar3125. Epub 2010 Sep 2.